MarketsStocksBIOFILCHEM
BI

Biofil Chemicals & Pharmaceuticals Limited

NSE: BIOFILCHEMBSE: 524396Healthcare
Download Research Report7-page PDF
35.70
+1.16%
NSE · auto-updates while market open
Prev Close
₹53.33
Day High
₹35.99
Day Low
₹34.66
Mkt Cap
₹57 Cr
P / E
20.4
P / B
2.6
ROE
13.8%
52W High
₹57.19
52W Low
₹25.60
Key Metrics
Market Cap
₹57 Cr
P / E
20.40
P / B
2.63
EV / EBITDA
87.96
ROCE
15.8%
ROE
13.8%
Debt / Equity
0.14
Book Value
₹13.25
EPS
₹1.71
Div Yield
0.0%
Face Value
-
Promoter Holding
46.8%
Revenue · ₹ Cr
22
FY22
30
FY23
40
FY24
33
FY25
28
FY26
Net Profit · ₹ Cr
1
FY22
1
FY23
1
FY24
1
FY25
3
FY26
EPS · ₹ per share
₹0.4
FY22
₹0.3
FY23
₹0.4
FY24
₹0.3
FY25
₹1.7
FY26
P / E Ratio · price ÷ TTM EPS
093186279210-0Mar 22Aug 23Jan 25Jun 26
P/E 20.6×Median 131.5×TTM EPS
Q1 2026 snapshot
Sales
₹8 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.13
Scorecard · 7 axes
Quality
Strong
82/100
Valuation
Good
20.4×
Growth
Strong
+23.7%
Profitability
Avg
14.8%
Performance
Bad
-35.2%
Entry Point
Good
62%
Red Flags
Strong
0 flags
Shareholding Pattern
46.8%Promoter
Promoter46.8%
DII0.1%
Public53.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue14.228.599.2613.60.937.67
Net Profit0.1650.22.4110.0840.0790.212
NPM %1.2%2.3%26.0%0.6%8.5%2.8%
AlertPre-trade